TECTONIC THERAPEUTIC, INC. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
TECTONIC THERAPEUTIC, INC. (TECX) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $96.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was $94.00K.
- TECTONIC THERAPEUTIC, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was -$5.00K.
- TECTONIC THERAPEUTIC, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$76.00K.
- TECTONIC THERAPEUTIC, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was -$95.00K.
- TECTONIC THERAPEUTIC, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$8.00K, a 150.00% decline from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $16.00K.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | $96.00K 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | $94.00K 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$95.00K 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$60.00K 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | -$37.00K 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | -$5.00K 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$8.00K 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$45.00K 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$60.00K 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | -$76.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $16.00K 10-K · filed 2025-03-20 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |